Close Menu

NEW YORK (GenomeWeb) – Life science and diagnostics company Meridian Bioscience reported before the opening of the market on Thursday that its second quarter revenues fell 1 percent, due to a decline in sales for its diagnostics segment.

For the three months ended March 31, the firm reported revenues of $51.3 million compared to revenues of $51.5 million in Q2 2015. Wall Street analysts had expected revenues of $52.1 million for the quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nobel laureates and scientific societies urge NIH and the Department of Health and Human Services to revisit the recent decision to end funding for a coronavirus grant.

Bloomberg reports that BGI's SARS-CoV-2 testing sites in the Middle East have raised concerns among US officials.

A new Pew Research Center poll finds confidence in medical researchers has grown among US adults since the start of the coronavirus pandemic.

In Science this week: machine learning algorithm for faster Mendelian disorder diagnoses, gene linked to safe response to nitrogen-containing bisphosphonates, and more.